Profile

Dr. Lindsey Shultz

Public Health Advisor, The Pandemic Tracking Collective

Lindsey is a physician and public health analyst from Pittsburgh, PA. She was a member of the Science Communication team at The COVID Tracking Project at The Atlantic and served as a senior science advisor and team lead for COVID Explained and COVID Act Now. Her broader interests include harm reduction, bioethics, and health systems.  Both prior to and after graduate school, she worked with Prevention Point Pittsburgh focusing on evidence-based drug policy. She received her undergraduate degrees from the Carnegie Mellon University Science and Humanities Scholars program in Biological Sciences and Ethics, History, and Public Policy. She earned her MD from Weill Cornell Medical College, where she was awarded The Gustave J. Noback Memorial Prize in Anatomy for student instruction, and trained for her MPH at Columbia University where she focused on the implementation of scientifically rigorous policy reform at both a national and international level. Lindsey was a 4-time jeopardy champion and a semi-finalist in the 2019 Tournament of Champions.

Authored Content

  • Nov 10 2022
    Blog Post The Increasing Burden of Dengue Fever in a Changing Climate When most people think of climate change, they envision melting icebergs and a rising sea level. While climate change is indeed warming the globe and causing the seas to rise, that is not the only detrimental effect. Disruption of weather patterns can include stronger and more frequent storms, droughts, wildfires, extreme flooding and heat waves. […] Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Lindsey Shultz, Rebecca Glassman, Samuel V. Scarpino
  • Aug 25 2022
    Blog Post There’s Something in the Air: Monitoring Indoor Air for SARS-CoV-2 Public health decisions about Covid-19 depend on knowledge about the level of SARS-CoV-2 circulating in a community. Clinical data obtained from individuals through nasal swab samples is crucial, but with a decrease in case reporting, in part due to increased home testing, the data needed to estimate disease prevalence is becoming less reliable. As an […] Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Kaitlyn Johnson, Lindsey Shultz, Rebecca Glassman
  • Jul 06 2022
    Field Note Tackling the Complexities of Covid-19 Wastewater Surveillance For more than two years, data derived from polymerase chain reaction (PCR) and rapid antigen tests on nasal swabs from individuals has been the primary source of data on Covid-19 in communities. As clinical testing data is becoming less reliably available, wastewater surveillance has emerged as a valuable epidemiological tool. It can detect the presence […] Jacqueline Houtman, Jonathan Gilmour, Lindsey Shultz, Megan Diamond, Rebecca Glassman
  • Jun 06 2022
    Blueprint The Challenge of Measuring Vaccine Effectiveness In mid-November 2020, as Covid-19 cases were rising and two thousand people were dying every day in the U.S., Americans needed hope. They got it. Hope arrived in a syringe. Effective vaccines were developed in record time, with the promise of ending the current pandemic. The scientific discoveries behind that quick vaccine development are also […] Dave Luo, Jacqueline Houtman, Lindsey Shultz, Samuel V. Scarpino
  • Apr 05 2022
    Blog Post A User’s Guide to U.S. Vaccine Breakthrough Rates With the United States over a year into its vaccination campaign, all eyes right now are on Covid-19 rates broken out by vaccination status—measures of the number of Covid-19 cases, hospitalizations, and deaths per 100,000 vaccinated or unvaccinated individuals. Shared by the U.S. Centers for Disease Control and Prevention (CDC) as well as many state, […] Dave Luo, Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Kaitlyn Johnson, Kara Schechtman, Leo Wolansky, Lindsey Shultz, Rebecca Glassman
Back to Top